Scopus Publication Detail
The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in Scopus. This abstract is what is used to create the fingerprint of the publication.
2′-Hydroxyflavanone inhibits prostate tumor growth through inactivation of AKT/STAT3 signaling and induction of cell apoptosis
Kaijie Wu; Zhongyun Ning; Jiancheng Zhou; Bin Wang; Jinhai Fan; Jianning Zhu; Yang Gao; Xinyang Wang; Jer-Tsong Hsieh; Dalin He(Profiled Author: Jer-Tsong Hsieh)
Oncology Reports. 2014;32(1):131-138.Abstract
Although there have been advances in therapeutic regimes for metastatic castration-resistant prostate cancer (CRPC), these recent developments have not led to improved cure rates. Thus, more novel agents to prolong patient survival are desired. 2′-Hydroxyflavanone (2HF), a nontoxic natural flavonoid, has been shown to exhibit pleiotropic anticancer effects in many cancer types, including prostate cancer (PCa). However, the therapeutic effects of 2HF on tumor growth and its potential mechanisms in CRPC have not been completely elucidated. In the present study, utilizing three different metastatic and androgen-independent PCa cell models (PC-3, DU145 and C4-2), we found that 2HF treatment not only resulted in inhibition of cell proliferation and colony formation in vitro, but also delayed subcutaneous tumor growth in vivo. Mechanistically, besides its known inhibitory effects on aldo-keto reductase activity and de novo a ndrogen synthesis, 2 HF also markedly suppressed AKT phosphorylation, signal transducer and activator of transcription-3 (STAT3) phosphorylation and transactivation subsequently regulating the expression of members of the BCL-2 family (i.e., Mcl-1, Bcl-2 and Bax) and modulating caspase-mediated cell apoptosis. Overall, this study revealed a novel mechanism for 2HF targeting metastatic CRPC, in which inactivation of AKT/STAT3 signaling led to cell apoptosis and growth inhibition.
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Ching-Ping Tseng; Brent D. Ely; Yingming Li; Rey-Chen Pong; Jer-Tsong HsiehEndocrinology. 1998;139(8):3542-3553.
D.C. Ihde; P.A. Bunn; M.H. Cohen; N.R. Dunnick; J.L. Eddy; J.D. MinnaCancer. 1980;45(6):1300-1310.
Jer-Tsong Hsieh; Hsi-Chin Wu; Martin E. Gleave; Andrew C. Von Eschenbach; Leland W. K. ChungCancer Research. 1993;53(12):2852-2857.
Appears in this Document